HDAC4 was declined in AIS patients vs. controls (median (IQR): 26.1 (18.4–45.1) pg/ml vs. 47.7 (35.9–56.2) pg/ml, p < 0.001) (Figure 1A). Here, HDAC4 is linked to androgen insensitivity syndrome.